All In Biotech

Drug Trial Radar · NCT00467844

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Double-Blind, Placebo-Controlled, Dose-Finding Study of the Effect of GTx-024 on Muscle Wasting (Cachexia) in Patients With Cancer

Last checked: Nov 19, 2026Latest source record: Jul 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 159 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

159

Actual

Start

May 2007

Primary completion

Sep 2008

Study completion Sep 2008

Sponsor

Lead sponsor
GTxIndustry
Sponsor type
Industry
First posted
May 1, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Supportive care
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess if Gtx-024 is effective in increasing lean body mass in subjects with muscle wasting related to cancer.

Conditions

  • Cachexia

Interventions

  • GTx-024Drug

    1 mg GTx 024

  • GTx-024Drug

    3 mg GTx-024

  • PlaceboDrug

    Matching Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Efficacy of GTx-024 on Total Body Lean Mass.Time frame: Baseline to Four Months

Locations

52 sites in 2 countries. Site status is shown where the registry gives one.

  • Alaska Cancer Research and Education Center

    Anchorage, Alaska

  • Highlands Oncology Group

    Fayetteville, Arkansas

  • Compassionate Cancer Care

    Corona, California

  • Compassionate Cancer Care Medical Group

    Fountain Valley, California

  • Pacific Coast Hematology/Oncology Medical Group, Inc.

    Fountain Valley, California

  • Desert Hematology Oncology Medical Group

    Rancho Mirage, California

  • Compassionate Cancer Care

    Riverside, California

  • Penrose Cancer Center

    Colorado Springs, Colorado

  • Dorcy Cancer Center

    Pueblo, Colorado

  • Hartford Hospital Cancer Clinical Research Office

    Hartford, Connecticut

  • Medical Oncology & Hematology, PC

    Waterbury, Connecticut

  • Gainesville Hematology Oncology Associates

    Gainesville, Florida

  • Horizon Institute for Clinical Research

    Hollywood, Florida

  • Hematology Oncology Associates

    Lake Worth, Florida

  • The Radiation Oncology Group

    Lake Worth, Florida

  • Watson Clinic LLP, Center for Cancer Care & Research

    Lakeland, Florida

  • Osler Medical

    Melbourne, Florida

  • Innovative Medical Research of South Florida, Inc.

    Miami, Florida

  • Florida Medical Clinic, PA

    Zephyrhills, Florida

  • Augusta Oncology Associates

    Augusta, Georgia

  • Dublin Hematology and Oncology

    Dublin, Georgia

  • Cancer Center of Kansas

    Wichita, Kansas

  • Kentuckiana Cancer Institute

    Louisville, Kentucky

  • Johns Hopkins University Clinical Trial Unit

    Baltimore, Maryland

  • Center for Cancer & Blood Disorders

    Bethesda, Maryland

  • The Center for Clinical Research WA County Hospital

    Hagerstown, Maryland

  • Newland Medical Center

    Southfield, Michigan

  • The West Clinic

    Corinth, Mississippi

  • West Clinic

    Corinth, Mississippi

  • The West Clinic

    Southaven, Mississippi

  • West Clinic

    Southaven, Mississippi

  • Hematology & Oncology Associates at Bridgeport

    Tupelo, Mississippi

  • Heartland Hematology-Oncology Associates

    Kansas City, Missouri

  • Donald H. Berdeaux, MD, FACP, PC

    Great Falls, Montana

  • Great Falls Clinic, LLP - Clinic Cancer Care

    Great Falls, Montana

  • Creighton University Hematology/Oncology Clinic

    Omaha, Nebraska

  • Cancer Care of Western North Carolina

    Ashville, North Carolina

  • Four Seasons Hospice & Palliative Care

    Flat Rock, North Carolina

  • Hanover Medical Specialists

    Wilmington, North Carolina

  • Gabrail Cancer Center

    Canton, Ohio

Showing 40 of 52 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.